Chemoradiation to Improve Local Control, and Thereby Overall Survival for Limited Stage Nasal NKTCL

This patient has Ann Arbor stage I disease of the nasal cavity with primary tumor invasion (PTI) into the maxillary sinus and paranasal tissues.1 Patients with favorable stage I disease may be considered for RT alone, however for higher risk patients (especially those with PTI and stage II NKTCL) combined modality therapy is pursued. We favor concurrent chemoradiation; this permits earlier integration of radiotherapy compared to...